Welcome to the E-Lab!
(Back
row, left to right: Addison, Brenna, Audrey, Ian,
Dr. Eagon, Adam, Slade, Brenden. Front row, left
to right: Ishita, Abby, Katherine, Victor &
Sal. Not pictured: Justin.)
(Back
row, left to right: Addison, Brenna, Audrey, Ian,
Dr. Eagon, Adam, Slade, Brenden. Front row, left
to right: Ishita, Abby, Katherine, Victor &
Sal. Not pictured: Justin.) Our research
group focuses on the development of small molecule
pharmaceuticals and probes, particularly those targeting
infectious diseases and cancer. Students are involved
in all aspects of drug synthesis and pre-clinical
development. Our group is also interested in
developing new synthetic methods to produce compounds
quickly & with minimal purification in an effort to
reduce development costs. Students majoring in
Chemistry, Biochemistry, or related majors are welcome to
join, but two quarters of organic chemistry lab are
normally required to join due to the complexity of
the chemistry involved. Current projects
include the development of kinase-based chemotherapy agents,
biological probes to better understand disease-related
proteins, new treatments to combat leishmaniasis,
the development of host-orientated compounds to combat
anthrax and the Ebola virus, and the development of new
classes of antibiotics to treat urinary tract infections.
*** Our lab is at California Polytechnic State University (Cal Poly). We wish we could host our website on the calpoly.edu domain to share the profiles, publications and successes of our research team, but the university has refused to support or host our webpage. Instead, we thank GitHub for their support of our lab and the open source docking resources we make available through our website.
*** Our lab is at California Polytechnic State University (Cal Poly). We wish we could host our website on the calpoly.edu domain to share the profiles, publications and successes of our research team, but the university has refused to support or host our webpage. Instead, we thank GitHub for their support of our lab and the open source docking resources we make available through our website.